EDAP TMS S.A. (EDAP)

Market Cap	79.77M
Revenue (ttm)	66.38M
Net Income (ttm)	-19.69M
Shares Out	37.10M
EPS (ttm)	-0.53
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	143,447
Open	2.290
Previous Close	2.220
Day's Range	2.052 - 2.430
52-Week Range	1.960 - 8.500
Beta	0.37
Analysts	Strong Buy
Price Target	11.75 (+446.51%)
Earnings Date	Mar 27, 2025

About EDAP

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urolog...

• Industry: Medical Distribution
• Sector: Healthcare
• IPO Date: Jul 31, 1997
• Employees: 307
• Stock Exchange: NASDAQ
• Ticker Symbol: EDAP
• Website: https://focalone.com

Financial Performance

In 2024, EDAP TMS's revenue was 64.12 million, an increase of 6.11% compared to the previous year's 60.42 million. Losses were -19.02 million, -10.20% less than in 2023.

Financial numbers in EUR

Analyst Forecast

According to 2 analysts, the average rating for EDAP stock is "Strong Buy." The 12-month stock price forecast is $11.75, which is an increase of 446.51% from the latest price.

Price Target

$11.75

(446.51% upside)

Analyst Consensus: Strong Buy